Ads
related to: merck- Order-To-Cash Services
We provide valuable expertise and
a 3PL infrastructure. Learn more.
- Quick Pricing
We answer requests within 24 hours.
Exceptional service
- Building Trust Since 1997
Tailored logistics solutions.
We increase supply chain efficiency
- Insights
Browse through our informative
posts and get valuable insights.
- Dedicated Team
Fast response time to requests.
Specialized account magement team.
- Title Model Solutions
We take title of the product on
behalf of the manufacturer.
- Order-To-Cash Services
Search results
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 5 days agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
What Makes Merck KGaA (MKGAF) a Good Fit for 'Trend Investing'
Zacks via Yahoo Finance· 6 days agoMerck KGaA (MKGAF) made it through our "Recent Price Strength" screen and could be a great choice...
Is Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?
Simply Wall St. via Yahoo Finance· 7 days agoMerck (NYSE:MRK) has had a rough month with its share price down 1.3%. To decide if this trend could...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 4 days agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed ...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 6 days agoHEALTH NEWS Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big...
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 13 hours agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis ...
Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Deals
Investor's Business Daily· 5 days agoDow Jones stalwart Merck and Surmodics announced big takeover deals Wednesday, but Merck stock...
Merck KGaA (MKGAF) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 5 days agoMerck KGaA (MKGAF) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 6 days agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Merck to acquire EyeBio in potential $3B deal
NJBIZ· 5 days agoOn Wednesday morning, Rahway-headquartered Merck announced it will acquire EyeBio in a deal that has a potential value of $3 billion. The agreement will bring EyeBio into ...
